What Can You Gain?

Access High-Value East Coast Buyers

Fast-track your pipeline by meeting qualified pharma and biotech decision-makers actively investing in next-gen tumor models and translational solutions.

Convert Visibility into Measurable Revenue

Showcase your expertise through speaking, panels, or exhibition exposure. Turn visibility into inbound interest and high-intent conversations onsite.

Maximize Brand Exposure Where It Drives Revenue

Stay front-of-mind with your target accounts through pre-event, onsite, and post-event visibility across website, brochure, and premium signage.

Unlock Actionable Market Intelligence

Hear directly from buyers shaping modeling strategies, validate demand, benchmark competitors, and refine your commercial positioning with real-time insights.

Key Services & Solutions

Our community of tumor modeling experts and senior decision makers are seeking service and solution providers with capabilities in the below areas but not limited to:

Optimizing patient-derived in vivo tumor models to empower efficacy and toxicology studies across novel modalities and indications

Developing and validating in vitro, complex in vitro, ex vivo and computational tumor models to advance early drug discovery through to assessing toxicity

Identifying and validating biomarkers to understand disease mechanisms and predict patients’ response to treatment with biomarker assays

Leveraging digital pathology & multi-omics tools to empower model selection, improve modeling techniques, identify underserved patient populations and predict effective treatment regimes

Analyzing deeper levels of disease complexity by implementing highly sensitive imaging technologies

If your expertise aligns with the above, then this meeting is an unmissable opportunity to position yourself alongside the leading voices in the field, elevate your solutions and services, and establish yourself as THE ‘go-to’ partner for biopharma for all things tumor modeling and preclinical oncology-related.

Hear What Our Past Sponsors Have to Say

ChemPartner-Logo-2023_Ombre_transparent_bg

This was my first time attending this conference and I found it very focused. The meeting agenda was clear and interesting. I especially enjoyed the speed networking program, which allowed me to get to know more attendees.

Senior Director, ChemPartner

images (1)

As always a good meeting with nice conversations.

Senior Director, Scientific Engagement and Key Accounts, Certis Oncology

HUB Organoids

Brings together a diverse group of people from industry.

Chief Executive Officer, Hub Organoids (part of Millipore Sigma)

image.imageformat.1286.1047946606

It is a good group to network with and discuss potential projects and deals at the ground/lab level.

Vice President of Global Sales, InSphero

Attending Companies Included

Available Inventory

We offer a flexible range of sponsorship opportunities designed to help you demonstrate scientific leadership, engage decision-makers, and align your brand with the future of tumor modeling innovation; from high-visibility packages to bespoke activations.

Tumor Models Summit Boston - Panel-Discussion
Poster-Entries-1
Networking-Sponsorships
Networking-2
15 (2)
Exhibition-Booth-Small

Get in Touch

Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us at sponsor@hansonwade.com if you would like to get involved and discuss a bespoke package suited to your needs.

28-768x432-1 (1)
Maintain Your Competitive Edge

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.

1-1-768x432-1 (1)
Network With Decision-Makers

Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.

13-768x432-1 (1)
Showcase Your Capabilities

Explore our bespoke sponsorship options including educating your target market through presentations to the entire audience or within a track, elevated branding, and exhibiting to build a package tailored to you and your company's goals.